By Dr. Shezad Malik, M.D., J.D. — Board-Certified Physician & Nationwide Product Liability Trial Attorney

Losing your vision to a prescribed medication is a terrifying and life-altering experience. Yet, this is the tragic reality facing thousands of people across the United States who were prescribed Ozempic, Wegovy, and other semaglutide weight-loss and diabetes drugs.

Patients experiencing sudden vision loss, dark shadows, or an “eye stroke” (NAION) after using semaglutide injections may qualify to file an Ozempic eye stroke lawsuit.

Medically Reviewed & Written by Dr. Shezad Malik, M.D., J.D., Board-Certified Physician & Trial Attorney

For decades, patients suffering from chronic, intractable neuropathic pain have been offered a seemingly miraculous solution: Spinal Cord Stimulation (SCS).

When defective medical devices fail, they often leave patients in worse pain than their original condition.

Dupixent® (dupilumab) is one of the most commonly prescribed biologic medications for eczema, asthma, and chronic sinus disease.

A medical‑legal expert analyzes dermatopathology slides and CTCL biopsy findings linked to Dupixent‑related lymphoma claims.

High-friction grinding between the cobalt-chromium ball and liner causes premature mechanical wear and leaches toxic metal ions directly into the surrounding joint tissue.

If you or a loved one received a hip replacement over the past two decades, you could be living with a ticking time bomb inside your body.

Clinical studies link popular weight-loss injections to Non-Arteritic Ischemic Optic Neuropathy (NAION), triggering national failure-to-warn lawsuits.

Losing your vision to a medication is terrifying. Yet, this is the tragic reality facing thousands of people taking Ozempic, Wegovy, and other semaglutide weight-loss and diabetes drugs.

Metal-on-Metal hip implants continue to fail prematurely at a high rate and may need a revision surgery to correct

Metal-on-Metal Hips: What’s the Problem?

Risks of Ozempic, A Focus on NAION. Ozempic, a popular medication containing semaglutide, is widely used for managing type 2 diabetes and aiding weight loss.

Ozempic use linked to NAION

California Depo-Provera Brain Cancer Lawsuit

On October 1, 2024, Kristina Schmidt from California filed the first Depo-Provera brain cancer product liability and personal injury lawsuit in the United States District Court Northern District of California.